With the evolution of covid variants, i believe this is one of the possible solution to serious covid reactions. It is competitors of course are vaccine makers.
Are we going to keep relying on vaccine makers. Or can we rely on something like what ENLV has?
Based on my research, ENLV is in the midst of trials and so far seems to be the only Israeli company, focusing on covid, that has gotten a subsidy from an Israel government agency.
The phase 2 trials are being conducted in Israel and Europe. None so far in the US.
However, it has recently filed a patent for the US.
In the meantime, I hope that we will see more positive news. Which without regular positive news, this stock will likely head downwards.
Are we going to keep relying on vaccine makers. Or can we rely on something like what ENLV has?
Based on my research, ENLV is in the midst of trials and so far seems to be the only Israeli company, focusing on covid, that has gotten a subsidy from an Israel government agency.
The phase 2 trials are being conducted in Israel and Europe. None so far in the US.
However, it has recently filed a patent for the US.
In the meantime, I hope that we will see more positive news. Which without regular positive news, this stock will likely head downwards.